1. Aurinia Pharmaceuticals Inc.

    0 Comments Leave a Comment

    1-3 of 3
    1. Mentioned In 3 Articles

    2. Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors

      Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors
      Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (Aurinia or the Company), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced the appointment of Timothy P. Walbert, chairman, president and chief executive officer (CEO) of Horizon Therapeutics plc, to the Companys Board of Directors...
      Read Full Article
    3. Aurinia Announces Updates to the Board of Directors

      Aurinia Announces Updates to the Board of Directors
      Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple inflammatory and autoimmune conditions, today announced the appointment of Ms. Jill Leversage to its Board of Directors and the resignation of Dr. Hyeuk Joon Lee...
      Read Full Article
    4. Aurinia Pharmaceuticals (AUPH) Appoints Dr. Daniel Billen to Board

      Aurinia Pharmaceuticals (AUPH) Appoints Dr. Daniel Billen to Board
      Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) today announced it has appointed Dr. Daniel Billen to its Board of Directors. Dr. Billens appointment is effective April 29, 2019 concurrent with the previously announced appointment of Mr. Peter Greenleaf as Chief Executive Officer and elevation of Dr. George Milne to Chairman of the Board...
      Read Full Article
    5. 1-3 of 3
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content